The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.00 (0.00%)
Spread: 0.04 (1.053%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.80
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PHC Granted Product Registration in Brazil

13 Jul 2015 07:00

RNS Number : 7882S
Plant Health Care PLC
13 July 2015
 

13 July 2015

 

 

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Plant Health Care's Technology Granted Product Registration in Brazil

 

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that it has received its first product registration in Brazil from the Brazilian Ministry of Agriculture. With this registration, the Company and its partners will be allowed to sell products based on its current generation of commercialized protein technology for foliar use on all crops.

 

Plant Health Care's protein technology is now approved for usage in 12 countries, including Brazil and the United States, which represent the two largest agricultural markets in the world. In addition, this registration allows the Company to move forward with the development and distribution agreement it signed with Arysta LifeScience in December, 2014 for foliar application of its technology to sugarcane in Brazil. Under that contract, Arysta LifeScience agreed to evaluate the Company's current protein technology across a range of geographical locations throughout Brazil and generate detailed information on increased biomass and sucrose production. In earlier studies, the technology showed significant and reliable increases in sugarcane yield. Pending consistent and reliable test results in the evaluation program, first sales of the product in Brazil are anticipated in the 2017 crop season.

 

Paul Schmidt, CEO of Plant Health Care, commented, "This registration is very significant to Plant Health Care as Brazil is the single largest agricultural market in the world. Sugarcane is one of the country's most important crops, covering more than 20 million acres, and a feedstock for the production of ethanol, which is a major component of Brazil's renewable fuel policy. Arysta LifeScience is a strong partner for the sugarcane market and we see the potential to establish a formidable position in this important sector."

 

João Marcos Ferrari, President & CEO of Arysta LifeSciences Do Brasil, commented, "We are excited to move forward with Plant Health Care in this collaborative effort. We have seen this technology provide significant increases in yield and sugar production in sugarcane and believe it will offer substantial benefits to growers. This is another important step toward our goal to be a leader in the applications of biological products in agricultural production."

 

The Company will issue interim results for the six months to June 30, 2015 on September 14, 2015.

 

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. In this way, Plant Health Care is capitalising on long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

About Arysta LifeScience: Arysta LifeScience, now owned by Platform Specialty Products, is a leading crop protection and life science company with 2014 revenues of US$2.2 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products that meet the needs of its global partners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALXEFSXSEFF
Date   Source Headline
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.